ArticleOncology and therapy2025

Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors.

Daphne W M Voogd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.